biological source
feline mammary glands
description
Mammary, carcinoma, feline
manufacturer/tradename
ECACC
packaging
tube of 5 μg 12122001-DNA-5UG, vial of cells 12122001-1VL
growth mode
Adherent
morphology
mixed population of polygonal cells
technique(s)
cell culture | mammalian: suitable
shipped in
dry ice
storage temp.
−196°C
Biochem/physiol Actions
CAT-MT is a feline mammary carcinoma cell line derived from a highly malignant tubular adenocarcinoma. CAT-MT cells are tumourigenic in athymic mice.
Preparation Note
EMEM (EBSS) + 2mM Glutamine + 10% Fetal Bovine Serum (FBS).
Split sub-confluent cultures (70-80%). Seed new cultures at 2-4 x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37°C.
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
Cultures from PHE Culture Collections and supplied by Sigma are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). No licensing agreement is required when either this cell line or the DNA extracted from it are used for internal research purposes only. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to culturecollections@ukhsa.gov.uk.